Scleritis: Immunopathogenesis and molecular basis for therapy
- 1 July 2013
- journal article
- review article
- Published by Elsevier BV in Progress in Retinal and Eye Research
- Vol. 35, 44-62
- https://doi.org/10.1016/j.preteyeres.2013.02.004
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Type I Interferon and Systemic Lupus ErythematosusJournal of Interferon & Cytokine Research, 2011
- Long-Term, Multicenter Evaluation of Subconjunctival Injection of Triamcinolone for Non-Necrotizing, Noninfectious Anterior ScleritisOphthalmology, 2011
- Neutrophils in the pathogenesis and manifestations of SLENature Reviews Rheumatology, 2011
- A Standardized Grading System for ScleritisOphthalmology, 2011
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisThe New England Journal of Medicine, 2010
- Cyclophosphamide for Ocular Inflammatory DiseasesOphthalmology, 2010
- Ocular disease in patients with ANCA-positive vasculitisJournal of Ocular Biology, Diseases, and Informatics, 2009
- Azathioprine for Ocular Inflammatory DiseasesAmerican Journal of Ophthalmology, 2009
- Long-term Risk of Malignancy Among Patients Treated With Immunosuppressive Agents for Ocular Inflammation: A Critical Assessment of the EvidenceAmerican Journal of Ophthalmology, 2008
- Evaluation of Subconjunctival Triamcinolone for Nonnecrotizing Anterior ScleritisOphthalmology, 2005